CME Group (NASDAQ:CME) Price Target Cut to $316.00 by Analysts at Rothschild & Co Redburn

CME Group (NASDAQ:CME) had its price objective reduced by Rothschild & Co Redburn from $340.00 to $316.00 in a report released on Monday,MarketScreener reports. They currently have a neutral rating on the financial services provider’s stock.

Several other research analysts have also weighed in on the company. Raymond James Financial lifted their target price on CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a report on Monday, April 6th. Deutsche Bank Aktiengesellschaft reduced their target price on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Jefferies Financial Group reduced their target price on CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a report on Thursday, April 9th. Argus reiterated a “hold” rating on shares of CME Group in a report on Wednesday, March 4th. Finally, Wall Street Zen lowered CME Group from a “hold” rating to a “sell” rating in a report on Sunday. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $305.29.

CME Group Stock Down 1.1%

Shares of CME Group stock opened at $281.94 on Monday. The company has a quick ratio of 1.03, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group has a 12 month low of $257.17 and a 12 month high of $329.16. The business has a fifty day simple moving average of $304.09 and a 200 day simple moving average of $286.47. The stock has a market cap of $101.11 billion, a PE ratio of 24.06, a price-to-earnings-growth ratio of 3.45 and a beta of 0.26.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.80 earnings per share. Research analysts predict that CME Group will post 12.24 EPS for the current year.

CME Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th were issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. This is a positive change from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date was Tuesday, March 10th. CME Group’s dividend payout ratio is presently 44.37%.

Insider Transactions at CME Group

In other news, Director Martin J. Gepsman sold 300 shares of the business’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $305.90, for a total value of $91,770.00. Following the sale, the director directly owned 24,999 shares in the company, valued at $7,647,194.10. The trade was a 1.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Dennis Suskind sold 748 shares of the business’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $300.00, for a total value of $224,400.00. Following the completion of the sale, the director owned 2,699 shares in the company, valued at approximately $809,700. This trade represents a 21.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 8,539 shares of company stock valued at $2,713,821. 0.30% of the stock is currently owned by company insiders.

Institutional Trading of CME Group

Institutional investors have recently modified their holdings of the company. West Family Investments Inc. grew its stake in CME Group by 1.2% in the 3rd quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock valued at $827,000 after buying an additional 37 shares in the last quarter. Rehmann Capital Advisory Group grew its stake in CME Group by 4.3% in the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after buying an additional 37 shares in the last quarter. Asset Dedication LLC grew its stake in CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 37 shares in the last quarter. Northwestern Mutual Investment Management Company LLC grew its stake in CME Group by 0.3% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock valued at $3,147,000 after buying an additional 37 shares in the last quarter. Finally, Atlatl Advisers LLC grew its stake in CME Group by 1.8% in the 3rd quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock valued at $574,000 after buying an additional 38 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.